251 results
Thumbnail

D1.69 - Safety in the peach juice food challenge in LTP allergic patients

Thumbnail

D1.70 - No more restrictive diets for LTP allergic patients. The importance of oral food challenge

Thumbnail

D1.71 - Risk Factors for Anaphylaxis in Food-Allergic Children During Oral Food Challenge Tests

Thumbnail

D1.72 - Comparison of the allergenic composition of available SPTs for the diagnosis of sensitization to D. pteronyssinus

Thumbnail

D2.413 - Association of sensitization to fur animal allergens and Bet v 1 in the Russian population

Thumbnail

D1.12 - Optimal Conventional Diagnostic Approach for Wheat Allergy in Chinese Children

Thumbnail

D1.34 - Hypersensitivity Reactions to Iodinated and Gadolinium-Based Contrast Media: Clinical and Epidemiological Insights

Thumbnail

D1.35 - Lipid transfer protein and Profilin-associated food-dependent exercise-induced anaphylaxis: A case series

Thumbnail

D1.36 - Prevalence of thaumatin and Alternaria co-sensitization

Thumbnail

D1.42 - Case Report of Allergy to Mint and Basil

Thumbnail

D1.43 - Performance Evaluation of a Semi-Quantitative Rapid Test Kit for Dust Mites: For Home Self-Monitoring and Control Effectiveness Assessment

Thumbnail

D1.46 - Allergic Reaction to Quadrivalent Meningococcal Conjugate Vaccine (MCV4): Case Report and Diagnostic Approach

Thumbnail

D1.57 - Antigen-specific IgE antibody levels as negative predictors of oral food challenge with cow's milk in children with cow's milk allergy

Thumbnail

D1.37 - Sometimes it is not what it seems

Thumbnail

D1.38 - Anaphylactic reaction to chia seeds: A case report

Thumbnail

100541 - Systematic evaluation of ChatGPT`s performance on 40 dermatological allergology questions with clinical error impact assessment for erroneous AI-guided chatbot-advice

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?